These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29378415)

  • 1. Severe Toxicity in Nonhuman Primates and Piglets with Systemic High-Dose Administration of Adeno-Associated Virus Serotype 9-Like Vectors: Putting Patients First.
    Flotte TR; Büning H
    Hum Gene Ther; 2018 Mar; 29(3):283-284. PubMed ID: 29378415
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN.
    Hinderer C; Katz N; Buza EL; Dyer C; Goode T; Bell P; Richman LK; Wilson JM
    Hum Gene Ther; 2018 Mar; 29(3):285-298. PubMed ID: 29378426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated Vector Toxicity-To Be or Not to Be?
    Büning H; Schmidt M
    Mol Ther; 2015 Nov; 23(11):1673-1675. PubMed ID: 26606658
    [No Abstract]   [Full Text] [Related]  

  • 4. Revisiting the "New" Inflammatory Toxicities of Adeno-Associated Virus Vectors.
    Flotte TR
    Hum Gene Ther; 2020 Apr; 31(7-8):398-399. PubMed ID: 32302233
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress with Recombinant Adeno-Associated Virus Vectors for Gene Therapy of Alpha-1 Antitrypsin Deficiency.
    Gruntman AM; Flotte TR
    Hum Gene Ther Methods; 2015 Jun; 26(3):77-81. PubMed ID: 26067712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses to recombinant adeno-associated virus vectors: putting preclinical findings into perspective.
    Flotte TR
    Hum Gene Ther; 2004 Jul; 15(7):716-7. PubMed ID: 15242531
    [No Abstract]   [Full Text] [Related]  

  • 7. Delivery of alpha- and beta-sarcoglycan by recombinant adeno-associated virus: efficient rescue of muscle, but differential toxicity.
    Dressman D; Araishi K; Imamura M; Sasaoka T; Liu LA; Engvall E; Hoffman EP
    Hum Gene Ther; 2002 Sep; 13(13):1631-46. PubMed ID: 12228018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How safe is a popular gene therapy vector?
    Kaiser J
    Science; 2020 Jan; 367(6474):131. PubMed ID: 31919200
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of serotype 5 adenoviral and serotype 2 adeno- associated viral vector-mediated gene transfer to salivary glands on the composition of saliva.
    Wang J; Voutetakis A; Mineshiba F; Illei GG; Dang H; Yeh CK; Baum BJ
    Hum Gene Ther; 2006 Apr; 17(4):455-63. PubMed ID: 16610933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials with Recombinant Adeno-Associated Viral Vectors: An Evolving Controversy.
    Ertl HCJ; High KA
    Hum Gene Ther; 2017 Apr; 28(4):328-337. PubMed ID: 28042943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia.
    Lebherz C; Gao G; Louboutin JP; Millar J; Rader D; Wilson JM
    J Gene Med; 2004 Jun; 6(6):663-72. PubMed ID: 15170737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA statement regarding the use of adeno-associated virus reference standard materials.
    Gavin DK
    Hum Gene Ther Methods; 2015 Feb; 26(1):3. PubMed ID: 25679057
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain.
    Serguera C; Bemelmans AP
    Rev Neurol (Paris); 2014 Dec; 170(12):727-38. PubMed ID: 25459120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus vectors in clinical trials.
    Carter BJ
    Hum Gene Ther; 2005 May; 16(5):541-50. PubMed ID: 15916479
    [No Abstract]   [Full Text] [Related]  

  • 15. Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial.
    Vandamme C; Adjali O; Mingozzi F
    Hum Gene Ther; 2017 Nov; 28(11):1061-1074. PubMed ID: 28835127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera®).
    Salmon F; Grosios K; Petry H
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):53-65. PubMed ID: 24308784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapleural administration of an AAVrh.10 vector coding for human α1-antitrypsin for the treatment of α1-antitrypsin deficiency.
    Chiuchiolo MJ; Kaminsky SM; Sondhi D; Hackett NR; Rosenberg JB; Frenk EZ; Hwang Y; Van de Graaf BG; Hutt JA; Wang G; Benson J; Crystal RG
    Hum Gene Ther Clin Dev; 2013 Dec; 24(4):161-73. PubMed ID: 24191907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5
    Majowicz A; Salas D; Zabaleta N; Rodríguez-Garcia E; González-Aseguinolaza G; Petry H; Ferreira V
    Mol Ther; 2017 Aug; 25(8):1831-1842. PubMed ID: 28596114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.
    Mack DL; Poulard K; Goddard MA; Latournerie V; Snyder JM; Grange RW; Elverman MR; Denard J; Veron P; Buscara L; Le Bec C; Hogrel JY; Brezovec AG; Meng H; Yang L; Liu F; O'Callaghan M; Gopal N; Kelly VE; Smith BK; Strande JL; Mavilio F; Beggs AH; Mingozzi F; Lawlor MW; Buj-Bello A; Childers MK
    Mol Ther; 2017 Apr; 25(4):839-854. PubMed ID: 28237839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion gene.
    Zhou X; Shen L; Liu L; Wang C; Qi W; Zhao A; Wu X; Li B
    Hum Vaccin Immunother; 2016 Mar; 12(3):732-9. PubMed ID: 26837862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.